Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata
Authors:
Top Cited Papers
- 1 October 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 160 (10) , 1075-1081
Abstract
Alopecia areata (AA) is a chronic autoimmune disease characterized by patchy or complete hair loss of any hair-bearing site that results from the collapse of hair follicle immune privilege.1 The oral Janus kinase (JAK) inhibitor baricitinib, administered at doses of 2 mg or 4 mg, once daily, demonstrated efficacy in achieving scalp hair regrowth over 52 weeks in 2 phase 3, double-blind, randomized clinical trials (BRAVE-AA1 and BRAVE-AA2) and has been approved for the treatment of adults with severe AA.2-4 More recently, the oral JAK3/TEC family inhibitor ritlecitinib has been approved for treating adults and adolescents with severe AA.5Keywords
This publication has 12 references indexed in Scilit:
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative ReviewDermatology and Therapy, 2023
- Baricitinib for the Treatment of Alopecia AreataDrugs, 2023
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trialThe Lancet, 2023
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)American Journal of Clinical Dermatology, 2023
- Two Phase 3 Trials of Baricitinib for Alopecia AreataNew England Journal of Medicine, 2022
- Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areataJournal of the American Academy of Dermatology, 2022
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia AreataAmerican Journal of Clinical Dermatology, 2020
- The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areataJournal of the American Academy of Dermatology, 2020
- Alopecia AreataNew England Journal of Medicine, 2012
- Management of alopecia areataBMJ, 2010